Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health
Boualem Sendid, Marjorie Cornu, Camille Cordier, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 2, pp. 103486-103486
Open Access | Times Cited: 13

Showing 13 citing articles:

Diagnosis and management of inflammatory bowel disease
Lili Li, Rui Cheng, Yushan Wu, et al.
Journal of Evidence-Based Medicine (2024) Vol. 17, Iss. 2, pp. 409-433
Closed Access | Times Cited: 13
Mycobiota and Antifungal Antibodies as Emerging Targets for the Diagnosis and Prognosis of Human Diseases
Eguzkiñe Díez-Martín, Leidi Hernández-Suárez, Egoitz Astigarraga, et al.
Journal of Fungi (2025) Vol. 11, Iss. 4, pp. 296-296
Open Access
MDIPID: Microbiota‐drug interaction and disease phenotype interrelation database
Jiayi Yin, Hui Ma, Yuting Qi, et al.
iMeta (2025)
Open Access
Candida and Long Covid: Mannan Not from Heaven
Patrick Chambers
Qeios (2024)
Open Access | Times Cited: 2
Veränderte T-Zell-Reaktion gegen Hefepilze bei chronischer Darmentzündung
Gabriela Rios Martini, Petra Bächer
BIOspektrum (2024) Vol. 30, Iss. 2, pp. 154-157
Open Access
Candida and Long Covid
Patrick Chambers
(2024)
Open Access
Candida and Long Covid
Patrick Chambers
(2024)
Open Access
Candida and Long Covid
Patrick Chambers
(2024)
Open Access
Circulating Autoantibodies in Adults with Hashimoto’s Thyroiditis: New Insights from a Single-Center, Cross-Sectional Study
Omar Tripolino, Maria Mirabelli, Roberta Misiti, et al.
Diagnostics (2024) Vol. 14, Iss. 21, pp. 2450-2450
Open Access
Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease
Tim Kaden, Raquel Alonso‐Román, Johannes Stallhofer, et al.
Advanced Healthcare Materials (2024)
Open Access
Exploring gut microbiota as a novel therapeutic target in Crohn’s disease: Insights and emerging strategies
Qiao Tong, Xian-Hui Wen
World Journal of Gastroenterology (2024) Vol. 31, Iss. 2
Closed Access
Fecal Mycobiota in Patients with Inflammatory Bowel Diseases and Extraintestinal Manifestations
Sandra Hertz, Hans Linde Nielsen, Sabrina Just Kousgaard, et al.
Gut Microbes Reports (2024) Vol. 1, Iss. 1, pp. 1-12
Open Access
Avancées dans le diagnostic biologique des maladies inflammatoires chroniques de l’intestin
Caroline Carlé, Chloé Bost, Guillaume Le Cosquer, et al.
Revue Francophone des Laboratoires (2024) Vol. 2024, Iss. 562, pp. 58-64
Closed Access
Page 1

Scroll to top